(Q73138873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related Lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

primary effusion lymphoma

1 November 2019

main subject

1 reference

2

Wyndham H. Wilson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Richard F. Little

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

Current infectious disease reports

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

176-184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations

1 November 2019

cites work

1 reference

12 December 2020

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

1 reference

12 December 2020

Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy

1 reference

12 December 2020

Chemotherapy for AIDS-related lymphomas

1 reference

12 December 2020

Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system.

1 reference

12 December 2020

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

12 December 2020

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial

1 reference

12 December 2020

Molecular pathogenesis of HIV-associated lymphomas

1 reference

12 December 2020

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

1 reference

12 December 2020

Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients

1 reference

12 December 2020

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group

1 reference

12 December 2020

Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma

1 reference

12 December 2020

Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy

1 reference

12 December 2020

Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

1 reference

12 December 2020

Variable morphology of human immunodeficiency virus-associated lymphomas with c-myc rearrangements. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors, I.

1 reference

12 December 2020

m-BACOD treatment for intermediate- and high-grade malignant lymphomas: a Southwest Oncology Group phase II trial

1 reference

12 December 2020

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

12 December 2020

Lymphocyte depletion during treatment with intensive chemotherapy for cancer

1 reference

12 December 2020

Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma

1 reference

12 December 2020

Epidemiology, clinical characteristics, and management of AIDS-related lymphoma

1 reference

12 December 2020

Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma

1 reference

12 December 2020

Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.

1 reference

12 December 2020

Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma

1 reference

12 December 2020

HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis

1 reference

12 December 2020

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

12 December 2020

Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity

1 reference

12 December 2020

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines

1 reference

12 December 2020

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas

1 reference

12 December 2020

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

12 December 2020

Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS

1 reference

12 December 2020

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

12 December 2020

Infusional CDE with rituximab for the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: preliminary results of a phase I/II study

1 reference

12 December 2020

Value of combined approach with thallium-201 single-photon emission computed tomography and Epstein-Barr virus DNA polymerase chain reaction in CSF for the diagnosis of AIDS-related primary CNS lymphoma

1 reference

12 December 2020

Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen.

1 reference

12 December 2020

Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas

1 reference

12 December 2020

bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma

1 reference

12 December 2020

Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss

1 reference

12 December 2020

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

12 December 2020

Malignant lymphomas associated with immunodeficiency states.

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia

1 reference

12 December 2020

Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

1 reference

12 December 2020

Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas

1 reference

12 December 2020

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

1 reference

12 December 2020

Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS.

1 reference

12 December 2020

Non-Hodgkin's lymphoma and AIDS: histopathologic features

1 reference

12 December 2020

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor.

1 reference

12 December 2020

Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males

1 reference

12 December 2020

Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment

1 reference

12 December 2020

Multidrug resistance (MDR-1) expression in AIDS-related lymphomas

1 reference

12 December 2020

Anti-CD20 monoclonal antibody (Rituximab) and Cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement

1 reference

12 December 2020

Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma

1 reference

12 December 2020

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

12 December 2020

Regression of AIDS-related pleural effusion with HAART. Highly active antiretroviral therapy

1 reference

12 December 2020

Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients

1 reference

12 December 2020

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

12 December 2020

The pathogenesis of AIDS lymphomas: a foundation for addressing the challenges of therapy and prevention

1 reference

12 December 2020

Prognostic implications of ploidy and proliferative activity in diffuse large cell lymphomas.

1 reference

12 December 2020

Differential expression of BCL-6, CD138/syndecan-1, and Epstein-Barr virus-encoded latent membrane protein-1 identifies distinct histogenetic subsets of acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.

1 reference

12 December 2020

Epidemiological and biological study of acquired immunodeficiency syndrome-related lymphoma in the County of Los Angeles: preliminary results

1 reference

12 December 2020

Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies

1 reference

12 December 2020

Outbreak of Burkitt's-like lymphoma in homosexual men.

1 reference

12 December 2020

Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. French-Italian Cooperative Group

1 reference

12 December 2020

Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain.

1 reference

12 December 2020

Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial

1 reference

12 December 2020

Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.

1 reference

12 December 2020

Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).

1 reference

12 December 2020

Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms

1 reference

12 December 2020

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

12 December 2020

Aids-Associated Malignant Lymphoma

1 reference

12 December 2020

Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma

1 reference

12 December 2020

Etiology and pathogenesis of AIDS-related non--Hodgkin's lymphoma

1 reference

12 December 2020

Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group.

1 reference

12 December 2020

Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco

1 reference

12 December 2020

10.1007/S11908-003-0055-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12642005%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference